Resveratrol prevents interleukin-1β-induced dysfunction of pancreatic β-cells

Journal of Biomedical Research - Tập 24 - Trang 381-388 - 2010
Fang Chen1, Xiaohua Zhou1, Yan Lin1, Changwen Jing1, Tao Yang2, Yong Ji3, Yujie Sun1, Xiao Han1
1Key Laboratory of Human Functional Genomics of Jiangsu Province, Clinical Diabetes Centre of Jiangsu Province, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China
2Department of Endocrinology, Jiangsu Diabetes Center, the First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China
3Atherosclerosis Research Centre, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China

Tài liệu tham khảo

Donath, 2008, Cytokines and betacell biology: from concept to clinical translation, Endocr Rev, 29, 334, 10.1210/er.2007-0033

Maedler, 2009, Interleukin-1 beta targeted therapy for type 2 diabetes, Expert Opin Biol Ther, 9, 1177, 10.1517/14712590903136688

Reimers, 1998, Interleukin-1 beta induced transient diabe-tes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus?, Dan Med Bull, 45, 157

Maedler, 2002, Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets, J Clin Invest, 110, 851, 10.1172/JCI200215318

Kato, 2003, Sup-pressive effects of a selective inducible nitric oxide syn-thase (iNOS) inhibitor on pancreatic beta-cell dysfunction, Diabetologia, 46, 1228, 10.1007/s00125-003-1173-x

Papaccio, 2005, A biphasic role of nuclear transcription factor (NF)-kappaB in the islet beta-cell apoptosis induced by inter-leukin (IL)-1beta, J Cell Physiol, 204, 124, 10.1002/jcp.20276

Li, 2008, iNOS gene silencing prevents inflam-matory cytokine-induced beta-cell apoptosis, Mol Pharm, 5, 407, 10.1021/mp700145f

Corbett, 1993, Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of langerhans, Proc Natl Acad Sci USA, 90, 1731, 10.1073/pnas.90.5.1731

Veluthakal, 2005, Essential role for membrane lipid rafts in IL-1beta-induced nitric oxide release from insulin-secreting cells: potential regulation by caveo-lin-1, Diabetes, 54, 2576, 10.2337/diabetes.54.9.2576

Veluthakal, 2005, Ceramide induces mitochondrial abnormalities in insulin-secreting INS-1 cells: potential mechanisms underlying ceramide-mediated metabolic dysfunction of the beta cell, Apoptosis, 10, 841, 10.1007/s10495-005-0431-4

Lagouge, 2006, Resveratrol Improves Mi-tochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1a, Cell, 127, 1109, 10.1016/j.cell.2006.11.013

Harikumar, 2008, Resveratrol: a multi-targeted agent for age-associated chronic diseases, Cell Cycle, 7, 1020, 10.4161/cc.7.8.5740

Silan, 2008, The effects of chronic resveratrol treatment on vascular responsiveness of streptozotocin-induced diabetic rats, Biol Pharm Bull, 31, 897, 10.1248/bpb.31.897

Borriello, 2010, Dietary polyphenols: Focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis, Nutr Metab Cardiovasc Dis, 20, 618, 10.1016/j.numecd.2010.07.004

Albani, 2010, Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence, J Alzheimers Dis, 19, 11, 10.3233/JAD-2010-1215

Chen, 2007, Resveratrol enhances insulin secretion by blocking K(ATP) and K(V) channels of beta cells, Eur J Pharmacol, 568, 269, 10.1016/j.ejphar.2007.04.062

Zunino, 2009, Type 2 diabetes and glycemic response to grapes or grape products, J Nutr, 139, 1794S, 10.3945/jn.109.107631

Thirunavukkarasu, 2007, Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase, Free Radic Biol Med, 43, 720, 10.1016/j.freeradbiomed.2007.05.004

Palsamy, 2008, Resveratrol, a natural phy-toalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats, Biomed Pharmacother, 62, 598, 10.1016/j.biopha.2008.06.037

Zhang, 2010, Resveratrol prevents the impairment of advanced glycosylation end products (AGE) on macrophage lipid homeostasis by suppressing the receptor for AGE via peroxisome pro-liferator-activated receptor gamma activation, Int J Mol Med, 25, 729

Floyd, 2008, Modulation of peroxisome proliferator-activated receptor gamma stability and transcriptional activity in adipocytes by resveratrol, Metabolism, 57, S32, 10.1016/j.metabol.2008.04.006

Ulrich, 2006, Peroxisome proliferator-activated receptor gamma as a molecular target of res-veratrol-induced modulation of polyamine metabolism, Cancer Res, 66, 7348, 10.1158/0008-5472.CAN-05-2777

Kim, 2007, Activation of peroxisome proliferator-activated receptor-gamma protects pancreatic beta-cells from cytokine-induced cytotoxicity via NF kappaB pathway, Int J Biochem Cell Biol, 39, 1260, 10.1016/j.biocel.2007.04.005

Han, 2001, Tissue inhibitor of metalloproteinase-1 prevents cytokine-mediated dys-function and cytotoxicity in pancreatic islets and beta-cells, Diabetes, 50, 1047, 10.2337/diabetes.50.5.1047

Han, 2002, Induction of cyclooxygenase-2 gene in pancreatic beta-cells by 12-lipoxygenase pathway product 12-hydroxyeicosa-tetraenoic acid, Mol Endocrinol, 16, 2145, 10.1210/me.2001-0300

Zhang, 2009, Inhibition of forkhead box O1 protects pancreatic beta-cells against dexamethasone-induced dysfunction, Endocrinology, 150, 4065, 10.1210/en.2009-0343

Zhang, 1989, Insulin secretion and cAMP metabolism in HIT cells. Reciprocal and se-rial passage-dependent relationships, Diabetes, 38, 44, 10.2337/diabetes.38.1.44

Eizirik, 1994, The inducible form of nitric oxide synthase (iNOS) in insulin-producing cells, Diabete Metab, 20, 116

Oyadomari, 2001, Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway, Proc Natl Acad Sci U S A, 98, 10845, 10.1073/pnas.191207498

Shakibaei, 2007, Resvera-trol inhibits IL-1 beta-induced stimulation of caspase-3 and cleavage of PARP in human articular chondrocytes in vitro, Ann N Y Acad Sci, 1095, 554, 10.1196/annals.1397.060

Csaki, 2008, Regulation of inflammation signalling by resveratrol in human chondrocytes in vitro, Biochem Pharmacol, 75, 677, 10.1016/j.bcp.2007.09.014

Cíz, 2008, The influence of wine polyphenols on reactive oxygen and nitrogen species production by murine macrophages RAW 264.7, Physiol Res, 57, 393, 10.33549/physiolres.931088

Djoko, 2007, Characterization of immunological activities of peanut stilbenoids, arachidin-1, piceatannol, and resveratrol on lipopolysac-charide-induced inflammation of RAW 264.7 macrophages, J Agric Food Chem, 55, 2376, 10.1021/jf062741a

Kim, 2006, Resveratrol inhibits inducible nitric oxide syn-thase and cyclooxygenase-2 expression in beta-amyloid-treated C6 glioma cells, Int J Mol Med, 17, 1069

Hisada, 2005, Per-oxisome proliferator-activated receptor gamma ligand prevents the development of chronic pancreatitis through modulating NF-kappaB-dependent proinflammatory cytokine production and pancreatic stellate cell activation, Rocz Akad Med Bialymst, 50, 142

Kwon, 1998, Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells, Diabetes, 47, 583, 10.2337/diabetes.47.4.583

Eldor, 2006, Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents, Proc Natl Acad Sci U S A, 103, 5072, 10.1073/pnas.0508166103

Kumar, 2010, NFKappaB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy, Biochem Biophys Res Commun, 394, 360, 10.1016/j.bbrc.2010.03.014

Thông tin
Thông tin xuất bản

Journal of Biomedical Research

Tập 24

381-388

Thông tin tác giả